Literature DB >> 1312116

On the cellular localization of the components of the herpes simplex virus type 1 helicase-primase complex and the viral origin-binding protein.

J M Calder1, E C Stow, N D Stow.   

Abstract

We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (UL5, UL8, UL9 and UL52) in the absence of any of the other proteins required for viral DNA synthesis. These viruses were used in immunofluorescence experiments to investigate the cellular localization of the four replication proteins expressed. The results demonstrated that all three components of the viral helicase-primase complex (UL5, UL8 and UL52 proteins) must be co-expressed to allow their efficient localization to the nucleus. Since the UL5 and UL52 proteins together form a complex which is enzymatically indistinguishable from a complex formed from all three proteins, a possible role of the UL8 protein may be in facilitating nuclear uptake. The UL9 protein (origin-binding protein) efficiently entered the cell nucleus when expressed alone. Both UL9 protein and the tripartite helicase-primase complex exhibited patterns of fluorescence which resembled the 'pre-replicative sites' described previously.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1312116     DOI: 10.1099/0022-1317-73-3-531

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  24 in total

1.  Nuclear localization of CBF1 is regulated by interactions with the SMRT corepressor complex.

Authors:  S Zhou; S D Hayward
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

2.  Conformational changes in the herpes simplex virus ICP8 DNA-binding protein coincident with assembly in viral replication structures.

Authors:  Susan L Uprichard; David M Knipe
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

3.  Properties of the novel herpes simplex virus type 1 origin binding protein, OBPC.

Authors:  K Baradaran; M A Hardwicke; C E Dabrowski; P A Schaffer
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

4.  Functional order of assembly of herpes simplex virus DNA replication proteins into prereplicative site structures.

Authors:  L M Liptak; S L Uprichard; D M Knipe
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

5.  Mutations in the putative zinc-binding motif of UL52 demonstrate a complex interdependence between the UL5 and UL52 subunits of the human herpes simplex virus type 1 helicase/primase complex.

Authors:  Yan Chen; Stacy D Carrington-Lawrence; Ping Bai; Sandra K Weller
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  Autographa californica multiple nucleopolyhedrovirus LEF-2 is a capsid protein required for amplification but not initiation of viral DNA replication.

Authors:  Carol P Wu; Yi-Ju Huang; Jen-Yeu Wang; Yueh-Lung Wu; Huei-Ru Lo; Jui-Ching Wang; Yu-Chan Chao
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

7.  Characterization of nuclear structures in cells infected with herpes simplex virus type 1 in the absence of viral DNA replication.

Authors:  C J Lukonis; S K Weller
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

8.  Replication of Epstein-Barr virus oriLyt: lack of a dedicated virally encoded origin-binding protein and dependence on Zta in cotransfection assays.

Authors:  E D Fixman; G S Hayward; S D Hayward
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

9.  Human cytomegalovirus primase UL70 specifically interacts with cellular factor Snapin.

Authors:  Ao Shen; Ji Lei; Edward Yang; Yonggang Pei; Yuan-Chuan Chen; Hao Gong; Gengfu Xiao; Fenyong Liu
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

10.  Inhibition of herpes simplex virus replication by a 2-amino thiazole via interactions with the helicase component of the UL5-UL8-UL52 complex.

Authors:  F C Spector; L Liang; H Giordano; M Sivaraja; M G Peterson
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.